WHO ICTRP trial
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by…
JPRN-UMIN000024686 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000024686 |
|---|---|
| Public title | Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by chemoradiotherapy concurrent with fractionated administration of high-dose cisplatin for patients with locally advanced squamous cell carcinoma of the head and neck |
| Scientific title | Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by chemoradiotherapy concurrent with fractionated administration of high-dose cisplatin for patients with locally advanced squamous cell carcinoma of the head and neck - TPF study for Japanese |
| Primary sponsor | National Cancer Center Hospital East |
| Secondary sponsors | Hyogo Cancer Center Hospital Jikei University School of Medicine Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Locally advanced head and neck cancer |
| Interventions | Induction chemotherapy(TPF) Docetaxel: 70-75mg/m2, day1 Cisplatin: 70-75mg/m2, day1 Fluorouracil: 750mg/m2, day1-5 q3w, total 3cycles Chemoradiotherapy(CRT) Cisplatin: 20mg/m2, day1-4 q3w, total 3cycles Radiation: 70Gy |
| Registration date | Feb 11, 2016 |
| Target size | 48 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: